Trial
NCT04598321
BrUOG 390: Neoadjuvant Treatment With Talazoparib
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Brown University
Collaborators
Pfizer; Lifespan
Condition
BRCA1 Mutation
Intervention
Talazoparib Oral Capsule
Why stopped
termination of research grant agreement
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-12